Extrawell Pharmaceutical (HKG:0858) expects a loss of between HK$450 million and HK$480 million for the six months ended Sept. 30, compared with a profit a year prior, a Thursday Hong Kong bourse filing said.

The pharmaceutical company attributed the forecast to a swing to an unrealized loss recognized on the fair value of its investments in certain convertible bonds.